Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Kazia Therapeutics Reports Early Efficacy Data from First Triple-Negative Breast Cancer Patient Receiving Paxalisib Combination Regimen achieving >50% Reduction in Circulating Tumor Cells in Phase 1b Trial 2025-07-09 20:00
First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418 2025-07-09 11:14
LakeShore Biopharma Announces US$15 Million Private Placement Financing 2025-07-08 19:25
WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities 2025-07-08 10:41
Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo) 2025-07-08 10:08
WuXi AppTec Receives MSCI ESG AAA Leader Rating 2025-07-07 20:08
Coreline Soft and Temple Health to Co-Host Webinar on AI-Driven Lung Cancer Screening and Improving Patient Outcomes 2025-07-07 20:00
The Voices of Persons Affected by Hansen's Disease Move the World: 3rd Global Forum Held in Bali, Indonesia 2025-07-07 19:00
Nuevocor Strengthens Board with Appointment of Thierry Abribat 2025-07-07 13:00
ESG | HitGen Releases Its Inaugural Sustainability Report 2025-07-04 19:00
NECC Selects MedMinder to Transform Their Medication Management for Individuals with Autism They Serve 2025-07-04 01:52
Fangzhou Tops China's App Store Chart for Healthcare Apps 2025-07-03 18:43
MOTE Therapeutics Taps MaryJane Rafii as Chief Investment & Business Officer to Drive Global Growth of RNA Delivery Platform 2025-07-03 18:07
Akeso's First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in 'IO+ADC' 2.0 Strategy 2025-07-03 14:46
Dizal's ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations 2025-07-03 08:08
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 2025-07-03 07:09
Ascletis Announces First Participants with Obesity or Overweight Dosed in a U.S. 13-week Phase IIa Study of Small Molecule Oral GLP-1R Agonist ASC30 2025-07-03 07:00
SeekInClarity: Blood-Based Multi-Omics Test Offers Promising Advance in Monitoring Cancer Treatment Response 2025-07-02 23:00
Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis 2025-07-02 21:00
Bon Announces Breakthrough Order for $16 Million Gut-Health Products 2025-07-02 20:00